Association of TLR4 Asp299Gly and Thr399Ile polymorphisms with Guillain-Barré syndrome in Northern Indian population

[1]  M. Netea,et al.  Functional Consequences of Toll-like Receptor 4 Polymorphisms , 2008, Molecular medicine.

[2]  I. Park,et al.  Rarity of TLR4 Asp299Gly and Thr399Ile Polymorphisms in the Korean Population , 2008, Yonsei medical journal.

[3]  U. Ghoshal,et al.  Association of Toll-like receptor-4 (Asp299Gly and Thr399Ileu) gene polymorphisms with gastritis and precancerous lesions. , 2007, Human immunology.

[4]  M. Netea,et al.  TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans , 2007, Proceedings of the National Academy of Sciences.

[5]  E. El-Omar,et al.  A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors. , 2007, Gastroenterology.

[6]  A. Crispin,et al.  The Role of Toll‐like Receptor 4 Asp299Gly and Thr399Ile Polymorphisms and CARD15/NOD2 Mutations in the Susceptibility and Phenotype of Crohn's Disease , 2005, Inflammatory bowel diseases.

[7]  J. Hampe,et al.  Association study of a functional Toll-like receptor 4 polymorphism with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma , 2005, Leukemia & lymphoma.

[8]  N. Tepley,et al.  MEG localization of language-specific cortex utilizing MR-FOCUSS , 2004, Neurology.

[9]  S. Akira,et al.  Toll-like receptors in innate immunity. , 2004, International immunology.

[10]  S. Pradhan,et al.  Detection of preceding Campylobacter jejuni infection by polymerase chain reaction in patients with Guillain-Barré syndrome. , 2004, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[11]  J. Laman,et al.  Functional polymorphisms in LPS receptors CD14 and TLR4 are not associated with disease susceptibility or Campylobacter jejuni infection in Guillain–Barré patients , 2004, Journal of Neuroimmunology.

[12]  J. Holloway,et al.  Polymorphisms in Toll-like receptor 4 and the systemic inflammatory response syndrome. , 2003, Biochemical Society transactions.

[13]  M. Iles,et al.  A biologically important single nucleotide polymorphism within the toll-like receptor-4 gene is not associated with rheumatoid arthritis. , 2003, Clinical and experimental rheumatology.

[14]  G. Mckhann,et al.  Differential Distribution of HLA-DQβ/DRβ Epitopes in the Two Forms of Guillain-Barré Syndrome, Acute Motor Axonal Neuropathy and Acute Inflammatory Demyelinating Polyneuropathy (AIDP): Identification of DQβ Epitopes Associated with Susceptibility to and Protection from AIDP1 , 2003, The Journal of Immunology.

[15]  S. Calvano,et al.  Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. , 2002, The Journal of infectious diseases.

[16]  D. Schwartz,et al.  Association between the Asp299Gly Polymorphisms in the Toll-like Receptor 4 and Premature Births in the Finnish Population , 2002, Pediatric Research.

[17]  D. Schwartz,et al.  Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. , 2002, Archives of internal medicine.

[18]  S. Akira,et al.  Toll-like receptors: critical proteins linking innate and acquired immunity , 2001, Nature Immunology.

[19]  D. Schwartz,et al.  Determination of the TLR4 genotype using allele-specific PCR. , 2001, BioTechniques.

[20]  J. Hoffmann,et al.  Toll receptors in innate immunity. , 2001, Trends in cell biology.

[21]  D. Schwartz,et al.  TLR4 mutations are associated with endotoxin hyporesponsiveness in humans , 2000, Nature Genetics.

[22]  F. Gusovsky,et al.  Toll-like Receptor-4 Mediates Lipopolysaccharide-induced Signal Transduction* , 1999, The Journal of Biological Chemistry.

[23]  R. Medzhitov,et al.  The Toll-receptor family and control of innate immunity. , 1999, Current opinion in immunology.

[24]  H. Hartung,et al.  Electrophysiological classification of guillain‐barré syndrome: Clinical associations and outcome , 1998, Annals of neurology.

[25]  I. Nachamkin,et al.  Campylobacter Species and Guillain-Barré Syndrome , 1998, Clinical Microbiology Reviews.

[26]  Jie Zhu,et al.  Cytokine production and the pathogenesis of experimental autoimmune neuritis and Guillain–Barré syndrome , 1998, Journal of Neuroimmunology.

[27]  G. Zhaori,et al.  A prospective clinical and electrophysiologic survey of acute flaccid paralysis in Chinese children , 1997, Neurology.

[28]  B. Allos.  Association between Campylobacter infection and Guillain-Barré syndrome. , 1997, The Journal of infectious diseases.

[29]  G. Mckhann,et al.  Pathology of the motor‐sensory axonal Guillain‐Barré syndrome , 1996, Annals of neurology.

[30]  K. Smith,et al.  Vascular changes and demyelination induced by the intraneural injection of tumour necrosis factor. , 1995, Brain : a journal of neurology.

[31]  M. Blaser,et al.  Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. , 1995, Brain : a journal of neurology.

[32]  G. Mckhann,et al.  Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases. , 1995, Brain : a journal of neurology.

[33]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[34]  A. Tattersfield,et al.  Guillain-Barre syndrome associated with Campylobacter infection. , 1982, British medical journal.

[35]  G. Orozco,et al.  Polymorphisms of toll-like receptor 2 and 4 genes in rheumatoid arthritis and systemic lupus erythematosus. , 2004, Tissue antigens.

[36]  S. Akira,et al.  Toll-like receptors. , 2003, Annual review of immunology.

[37]  D. Cornblath,et al.  Assessment of current diagnostic criteria for Guillain‐Barré syndrome , 1990, Annals of neurology.